Navigation Links
BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
Date:9/17/2013

a Phase 1/2, open-label study at two sites in France to evaluate the efficacy, safety and tolerability of BL-8020 in patients infected with HCV. The study will include up to 32 HCV-infected patients of any genotype who have previously failed or relapsed following treatment with the standard-of-care. BL-8020 is a proprietary oral, fixed-dose combination treatment composed of Ribavirin and Hydroxychloroquine (HCQ). The primary endpoint of the study is to evaluate the effect of a 16-week combination therapy with Ribavirin and HCQ. The study is specifically designed to allow intra-subject analysis, in order to determine the extent to which HCQ enhances Ribavirin's antiviral activity.


 

About BL-8020
BL-8020 is a proprietary fixed-dose combination treatment composed of Ribavirin and Hydroxychloroquine (HCQ). Efficacy results in replicon assays, as well as in ex-vivo infected human liver samples, showed a time and dose-dependent inhibitory effect of BL-8020 on HCV replication and infectivity. In addition, a synergistic effect with other anti-HCV agents was observed in these models. This effect on other therapies is likely to increase their potency and reduce the numerous adverse effects often associated with these drugs by reducing their effective doses. BL-8020 targets the infected host cells and inhibits HCV induced autophagy in the host. This unique mechanism of action differentiates BL-8020 from other currently used anti-HCV agents in its potential pan genotypic activity and high genetic barrier to resistance (low susceptibility for drug-resistant mutations to be developed by the virus). BL-8020 was licensed under a worldwide, exclusive agreement from Genoscience, a French company focused on viral disease therapeutics. It was developed as an anti-viral therapy by Professor Philippe Halfon, Co-Founder and President of Genoscience and a world-renowned scientist for his work on HIV, H
'/>"/>

SOURCE BioLineRx Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
2. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
3. BioLineRx to Present at 15th International Celiac Disease Symposium
4. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
5. BioLineRx Appoints B. J. Bormann to Board of Directors
6. BioLineRx Reports Second Quarter 2013 Results
7. BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
8. Celtaxsys Announces Successful Completion of Phase 1 Clinical Trial for Development of CTX-4430
9. Freudenberg-NOK Sealing Technologies Announces Screw Connections Based on Hygienic Design Consistently Achievable
10. Plastic Surgeon Dr. Marc J. Salzman Announces Use of Astanza Trinity Laser Tattoo Removal System, Runs Limited-Time Promotion
11. Sam Solakyan announces Paramount Management Services is now a full-scale MSO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015  MedAptus® today ... solution designed to simplify pre-care needs for busy ... intelligence to automatically assign patients to hospitalists or ... of care and other requirements such as ensuring ... ...
(Date:3/30/2015)... March 30, 2015  Orexigen Therapeutics, Inc. (Nasdaq: ... Cannell has joined as Chief Commercial Officer. ... Contrave® /Mysimba™ (naltrexone HCl / bupropion HCl extended ... global commercial strategy, assuming responsibilities previously held by ... commercial effort through the U.S. launch of Contrave, ...
(Date:3/30/2015)... Calif. , March 30, 2015  Cochlear ... has decided to leave Cochlear to join Valencia ... and friend, Jeff Greiner , who is ... Chief of Market Development and will be responsible ... of Valencia,s coin-sized neuromodulation ...
Breaking Medicine Technology:MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 2MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10Cochlear VP of U.S. Sales Jerry Schloffman Accepts Chief of Market Development Position at Valencia Technologies 2
(Date:3/30/2015)... 30, 2015 Follow us on ... to develop and establish chronic pain rehabilitation centers are ... the market is poised to benefit from the rise ... the increase in chronic health conditions such as Cancer, ... among others. While conventional treatment for pain management is ...
(Date:3/30/2015)... This report studies the global pharmacovigilance and ... of 2014 to 2019. This market is expected ... 2014 to 2019. , Further Inquiry @ ... pharmacovigilance and drug safety software market has been ... functionality, namely, adverse event reporting software, drug safety ...
(Date:3/30/2015)... March 30, 2015 Tel-Aviv – March ... prescription eyewear, announced the closing of $12.5 million in ... of the Viola Group. The funding will further GlassesUSA's ... leading player in the growing global market of online ... in 2009 by CEO Daniel Rothman, COO Eldad Rothman, ...
(Date:3/30/2015)... 30, 2015 On March 19th, 2015, ... home of the Detroit Lions, LiveToBeSober.org hosted the “Fighting ... pastors, ministers and bishops as well as other civic ... audience at the luncheon, including retired Detroit Lions wide ... Wickstrom and two survivors of their own personal battles ...
(Date:3/30/2015)... New York, New York (PRWEB) March 30, 2015 ... of its Top 10 Exotic Water Awards, with the top ... other winners are listed on the company’s website, along with ... Water’s website, exotic water, glacial water, spring water, mineral water ... Fiji water is one of the top exotic water ...
Breaking Medicine News(10 mins):Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2Health News:Best Exotic Water Brands Acclaimed by 10 Best Water 2
... study conducted by India and Canada which was carried out by ... decrease in the HIV prevalence. The data revealed that women ... of Tamil Nadu, Maharashtra, Karnataka and Andhra Pradesh had fallen from ... mainly seen in the four south Indian states. , ...
... Heart Journal has said that prayers do not seem to ... recently underwent cardiac bypass surgery. // On the contrary, prayers ... that their condition was far worse than thought. ... and the Baptist Memorial Health Care Corp, tracked the progress ...
... yet to receive AIDS medications from government-funded programs, which are ... to buy costly treatments, //according to an annual survey in ... states were also forced to cut down on the medications ... due to a shortage of funds. "The need for HIV-related ...
... babies who were given an aid to help them breathe ... The way was CNEP therapy - continuous negative-extrathoracic pressure. // ... researchers to the original trial in the early 1990s. ... Southall. ,The Nottingham researchers followed up 133 of ...
... Cephalon has been accorded a further six months of ... disorder treatment medication//, Provigil. ,Cephlaon had ... that entailed the provision of clinical studies data after ... ,Cephalon has settled the ‘provogil’patent infringement litigation with ...
... Australia’s crippled mental health services and community-based care centres. ... would triple for Australia's mental health services and hundreds ... the Government accepts the demands of a parliamentary committee. ... patients from institutions into the community. ...
Cached Medicine News:
... Korchek Technologies CareChek Rx ... barcode technology, Windows CE ... integrated scanners (to perform ... the bedside) and an ...
... Safety Infusion System is designed to ensure ... and the right dose. Available in four ... Safety Infusion System allows hospitals to choose ... their needs. DoseGuard™ dose limit technology and ...
... has an installed base of field-proven ... world. Hospital departments using Intermec media ... Supply, Admissions, Nursing Stations, Pharmacy, Medical ... labeling materials includes many products that ...
... Positive Patient Identification™ (PPI) system is an automated solution that identifies the patient, tying all critical information to ... ... ... ...
Medicine Products: